"XUZHISHI" Clinches Over 50 Million Yuan in A+ Round Funding
3 week ago / Read about 0 minute
Author:小编   

Towards the close of 2025, AI-driven medical innovation firm "XUZHISHI" proclaimed the successful closure of its A+ round of funding, amassing over 50 million yuan. This funding round witnessed joint participation from Zheshang Capital, Xiangtai Capital, and Plum Ventures.

The proceeds will be predominantly channeled towards the advancement of an AI algorithm framework tailored for brain-specific ailments, the construction of multimodal neural data models, the aggregation of tangible AI training datasets, and the research and development endeavors surrounding XR brain-computer interface hardware.

XUZHISHI further divulged that the company is diligently gearing up for its Series B funding round, slated to kick off post the Spring Festival.